Keflex (cephalexin) is the preferred initial choice for periorbital cellulitis
For periorbital cellulitis without purulent drainage or abscess, treat with cephalexin (Keflex) alone. If an abscess is confirmed, incision and drainage is the primary treatment, with antibiotics playing an adjunctive role.
Clinical Decision Algorithm
Step 1: Rule Out Abscess
- Perform soft tissue ultrasound or CT imaging if clinically indicated to definitively exclude abscess
- If abscess is present: incision and drainage is the primary treatment 1
- Systemic antibiotics are usually unnecessary for simple abscesses unless fever or systemic signs are present 1
Step 2: Assess for MRSA Risk Factors
For true cellulitis (non-purulent), streptococci are the predominant pathogens 1. MRSA coverage is NOT routinely needed unless specific risk factors are present 1:
MRSA risk factors requiring dual coverage:
- Penetrating trauma
- Purulent drainage (suggests abscess, not pure cellulitis)
- Evidence of MRSA infection elsewhere
- Nasal MRSA colonization
- Injection drug use
- Systemic inflammatory response syndrome (SIRS)
Step 3: Choose Antibiotic Regimen
Without MRSA risk factors (most cases):
- Cephalexin 500 mg PO four times daily for 5-7 days 1, 2
- This provides excellent streptococcal coverage, which is the primary pathogen in non-purulent cellulitis
With MRSA risk factors:
- Add trimethoprim-sulfamethoxazole (Bactrim) to cephalexin for dual coverage 1
- Alternative: Clindamycin alone (covers both streptococci and MRSA)
Why Not Bactrim Alone?
Bactrim monotherapy is inadequate for typical cellulitis because its activity against β-hemolytic streptococci is unreliable 1. A high-quality 2017 randomized controlled trial demonstrated that cephalexin plus trimethoprim-sulfamethoxazole was no more effective than cephalexin alone for uncomplicated cellulitis without purulent drainage (83.5% vs 85.5% cure rates, p=0.50) 3. This confirms that adding MRSA coverage provides no benefit in typical cases.
Evidence Strength and Nuances
The 2014 IDSA guidelines provide strong, moderate-quality evidence that typical cellulitis should receive anti-streptococcal therapy alone 1. The guidelines explicitly state that MRSA is an unusual cause of typical cellulitis, with one prospective study showing 96% success with β-lactams like cefazolin or oxacillin 1.
Important caveat for periorbital location: While the general SSTI guidelines apply, periorbital cellulitis has unique anatomic considerations. A 2025 survey found significant practice variation, with most sites using cephalexin for preseptal cellulitis but escalating to broader coverage for orbital involvement 4. If there's concern for orbital extension (proptosis, ophthalmoplegia, vision changes), immediate ophthalmology consultation and IV antibiotics are required.
Common Pitfalls to Avoid
- Don't assume MRSA without risk factors - This leads to unnecessary broad-spectrum coverage and increased adverse effects
- Don't use Bactrim monotherapy - It lacks reliable streptococcal coverage, the primary pathogen
- Don't miss an abscess - If purulent drainage or fluctuance is present, this is NOT simple cellulitis and requires drainage 1
- Don't overlook orbital involvement - Any vision changes, restricted eye movement, or proptosis requires immediate escalation of care
Treatment Duration and Follow-up
- 5 days of therapy is sufficient if clinical improvement occurs by day 5 1
- Extend treatment if no improvement within 5 days
- Follow-up at 48-72 hours to assess response